Simplify Asset Management Inc. Purchases 42,661 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Simplify Asset Management Inc. raised its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 197.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 64,300 shares of the company's stock after purchasing an additional 42,661 shares during the quarter. Simplify Asset Management Inc. owned 0.23% of Establishment Labs worth $2,962,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Barclays PLC raised its position in Establishment Labs by 9,643.3% during the third quarter. Barclays PLC now owns 31,471 shares of the company's stock valued at $1,362,000 after buying an additional 31,148 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Establishment Labs by 89.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 41,351 shares of the company's stock valued at $1,789,000 after purchasing an additional 19,531 shares during the period. Assenagon Asset Management S.A. purchased a new stake in shares of Establishment Labs in the fourth quarter worth approximately $12,898,000. Vestal Point Capital LP acquired a new stake in shares of Establishment Labs during the third quarter worth approximately $1,731,000. Finally, Point72 Asset Management L.P. increased its stake in Establishment Labs by 210.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 49,400 shares of the company's stock valued at $2,138,000 after buying an additional 33,507 shares during the period. Hedge funds and other institutional investors own 72.91% of the company's stock.

Remove Ads

Establishment Labs Stock Up 1.8 %

ESTA stock traded up $0.72 during trading hours on Thursday, hitting $40.64. The company's stock had a trading volume of 205,025 shares, compared to its average volume of 420,358. The company has a market capitalization of $1.17 billion, a PE ratio of -15.75 and a beta of 0.95. The stock has a 50 day moving average price of $36.24 and a two-hundred day moving average price of $40.84. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 12 month low of $28.16 and a 12 month high of $60.12.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The company had revenue of $44.51 million for the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. On average, equities research analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Stephens reissued an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.